Cutaneous manifestations of DOCK8 deficiency syndrome

Archives of Dermatology

Volumn 148, Issue 1, 2012, Pages 79-84

  Chu, Emily Y ^a,c   Freeman, Alexandra F ^b   Jing, Huie ^b   Cowen, Edward W ^a   Davis, Joie ^b   Su, Helen C ^b   Holland, Steven M ^b   Chanco Turner, Maria L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CIDOFOVIR; CIMETIDINE; DOXYCYCLINE; IMIQUIMOD; IMMUNOGLOBULIN E; PREDNISONE; RIFAMPICIN; SALICYLIC ACID; STEROID; VALACICLOVIR;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; COARSE FACE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DEDICATOR OF CYOKINESIS 8 GENE; DEDICATOR OF CYTOKINESIS 8 GENE DEFICIENCY SYNDROME; DERMATITIS; DIFFERENTIAL DIAGNOSIS; ECZEMA; FEMALE; FOOD ALLERGY; GENE MUTATION; GENITAL HERPES; GROIN ULCERATION; HERPES SIMPLEX KERATITIS; HERPES VIRUS INFECTION; HUMAN; HYPER IGE SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; KAPOSI VARICELLIFORM ERUPTION; LARGE CELL LYMPHOMA; LUNG ASPERGILLOSIS; LUNG INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLLUSCUM CONTAGIOSUM; NEWBORN RASH; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RECURRENT VIRUS INFECTION; REGULATOR GENE; SCHOOL CHILD; SKIN ABSCESS; SKIN MANIFESTATION; STAPHYLOCOCCAL PNEUMONIA; UTERINE CERVIX CARCINOMA; VAGINA CANDIDIASIS; VERRUCA VULGARIS; VIRAL SKIN DISEASE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INFANT; JOB'S SYNDROME; MALE; MUTATION; SKIN DISEASES; SYNDROME; YOUNG ADULT;

EID: 84856022081     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.262     Document Type: Article

References (29)

1. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046-2055.
2. Eberting CL, Davis J, Puck JM, Holland SM, Turner ML. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004;140(9):1119-1125. (Pubitemid 39223120)
3. Freeman AF, Holland SM. Clinical manifestations of hyper IgE syndromes. Dis Markers. 2010;29(3-4):123-130.
4. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608-1619. (Pubitemid 47598403)
5. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157): 1058-1062. (Pubitemid 47345590)
6. Renner ED, Puck JM, Holland SM, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144(1):93-99. (Pubitemid 38091428)
7. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25(5):745-755. (Pubitemid 46131400)
8. Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-1302, e4.
9. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis, III: independent hospital validation. Br J Dermatol. 1994;131(3):406-416. (Pubitemid 24290228)
10. Lei JY, Wang Y, Jaffe ES, et al. Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma. Am J Dermatopathol. 2000;22(6):524-529. (Pubitemid 32054847)
11. Freeman AF, Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res. 2009;65(5, pt 2):32R-37R.
12. Zhang Q, Davis JC, Dove CG, Su HC. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers. 2010;29(3-4):131-139.
13. McGhee SA, Chatila TA. DOCK8 immune deficiency as a model for primary cytoskeletal dysfunction. Dis Markers. 2010;29(3-4):151-156.
14. Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol. 2008;122(6):1054-1064.
15. Al Khatib S, Keles S, Garcia-Lloret M, et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol. 2009;124(2):342-348, 348, e1-e5.
16. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452 (7188):773-776. (Pubitemid 351521078)
17. Su HC. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol. 2010;10(6):515-520.
18. Idbaih A, Carvalho Silva R, Crinière E, et al. Genomic changes in progression of low-grade gliomas. J Neurooncol. 2008;90(2):133-140.
19. Kang JU, Koo SH, Kwon KC, Park JW. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol. 2010;37(2):327-335.
20. Saelee P, Wongkham S, Puapairoj A, et al. Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma. Asian Pac J Cancer Prev. 2009;10(3):501-506.
21. Takahashi K, Kohno T, Ajima R, et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. Int J Oncol. 2006;28(2):321-328.
22. Boztug K, Schmidt M, Schwarzer A, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med. 2010;363(20):1918-1927.
23. Friedrich W, Schütz C, Schulz A, Benninghoff U, Hönig M. Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors. Immunol Res. 2009;44(1-3):18-24.
24. Schuetz C, Hoenig M, Gatz S, et al. Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res. 2009; 44(1-3):35-41.
25. Seger RA. Hematopoietic stem cell transplantation for chronic granulomatous disease. Immunol Allergy Clin North Am. 2010;30(2):195-208.
26. Barlogis V, Galambrun C, Chambost H, et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency [published online May 3, 2011]. J Allergy Clin Immunol. doi:10.1016/j.jaci.2011.03.025.
27. Bittner TC, Pannicke U, Renner ED, et al. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr. 2010;222(6):351-355.
28. Gatz SA, Benninghoff U, Schutz C, et al. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2010;46(4):552-556.
29. McDonald DR, Massaad MJ, Johnston A, et al. Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2010;127(1):30-38.